Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC).

Howard L. Kaufman; Thomas Amatruda; John Nemunaitis; Jason Chesney; Keith A. Delman; Lynn E. S̄pitler; Frances A. Collichio; Merrick I. Ross; Yang Zhang; Mark Shilkrut

doi:10.1200/jco.2015.33.15_suppl.9074

Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC).

Identifier:nobleid.org/w1/20260515/CD7EE97E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD7EE97E.svg?ark=w1%2F20260515%2FCD7EE97E)](https://nobleid.org/work/w1/20260515/CD7EE97E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC).

Identifier:nobleid.org/w1/20260515/CD7EE97E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD7EE97E.svg?ark=w1%2F20260515%2FCD7EE97E)](https://nobleid.org/work/w1/20260515/CD7EE97E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work